Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2024
Q1
Sell
-1,046
Closed -$114K 176
2023
Q4
$114K Sell
1,046
-2,972
-74% -$308K 0.03% 100
2023
Q3
$414K Sell
4,018
-1,723
-30% -$186K 0.17% 64
2023
Q2
$662K Buy
5,741
+2,180
+61% +$248K 0.1% 73
2023
Q1
$379K Buy
3,561
+2,077
+140% +$224K 0.05% 94
2022
Q4
$165K Buy
1,484
+382
+35% +$39K 0.03% 108
2022
Q3
$95K Hold
1,102
0.04% 141
2022
Q2
$100K Hold
1,102
0.03% 161
2022
Q1
$90K Hold
1,102
0.03% 194
2021
Q4
$84K Buy
1,102
+345
+46% +$27.5K 0.02% 222
2021
Q3
$57K Buy
757
+512
+209% +$38.9K 0.02% 243
2021
Q2
$19K Sell
245
-12
-5% -$893 0.01% 248
2021
Q1
$19K Hold
257
0.01% 306
2020
Q4
$20K Sell
257
-448
-64% -$34.3K 0.01% 149
2020
Q3
$56K Hold
705
0.03% 101
2020
Q2
$52K Buy
705
+203
+40% +$15.3K 0.03% 102
2020
Q1
$37K Sell
502
-366
-42% -$28.8K 0.02% 132
2019
Q4
$75K Hold
868
0.05% 100
2019
Q3
$70K Hold
868
0.04% 90
2019
Q2
$69K Hold
868
0.03% 121
2019
Q1
$69K Hold
868
0.05% 109
2018
Q4
$63K Buy
868
+419
+93% +$29.6K 0.04% 103
2018
Q3
$30K Hold
449
0.02% 160
2018
Q2
$26K Sell
449
-38
-8% -$2.14K 0.02% 94
2018
Q1
$25K Buy
+487
New +$26.3K 0.02% 98

Other funds holding MRK

Arlington Partners's MRK Position: Q1 2024 in Review

Arlington Partners sold out of Merck (MRK) in Q1 2024, closing a stake of 1,046 shares — an estimated $114K sold.

Arlington Partners first reported a position in MRK in Q1 2018 and held it in 24 quarters. The position peaked at $662K in Q2 2023. 3,535 funds tracked by Wall St. Rank hold MRK as of Q1 2024.

  • Arlington Partners reported no remaining Merck position as of Q1 2024 after selling out during the quarter.
  • Arlington Partners sold 1,046 Merck shares in Q1 2024, an estimated $114K.
  • Arlington Partners first reported a position in Merck in Q1 2018 and held it in 24 quarters.
  • Arlington Partners's Merck position peaked at $662K in Q2 2023.
  • 3,535 funds tracked by Wall St. Rank held Merck as of Q1 2024.

Based on Arlington Partners's 13F filing for Q1 2024, filed 16 Apr 2024.